Influence of sex on treatment and outcome in chronic heart failure. - Wikidata - wikimedia - TriplyDB

Influence of sex on treatment and outcome in chronic heart failure.

Influence of sex on treatment and outcome in chronic heart failure.

http://www.wikidata.org/entity/Q37877792

about

Clinical and gender differences in heart transplant recipients in the NEW HEART study Prevalence of Heart Failure and Adherence to Process Indicators: Which Socio-Demographic Determinants are Involved?Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score.Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.

P2860

Q33926224-EA1E7103-E573-4A60-B95E-BF5ED6061905 Q36633996-130DDA05-C178-4598-B126-6CB0D7E048B6 Q37454789-A2DDE0D9-5D28-41BF-9F3C-F3EC305E8B69 Q44050644-5BB0A9E1-7B53-4A2E-8818-B8BB70733794 Q55118810-C5FAC694-8159-45B2-B4BD-4AC1C03329A0

P2860

Influence of sex on treatment and outcome in chronic heart failure.

http://www.wikidata.org/entity/Q37877792

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Influence of sex on treatment and outcome in chronic heart failure.

@en

Influence of sex on treatment and outcome in chronic heart failure.

@nl

type

label

Influence of sex on treatment and outcome in chronic heart failure.

@en

Influence of sex on treatment and outcome in chronic heart failure.

@nl

prefLabel

Influence of sex on treatment and outcome in chronic heart failure.

@en

Influence of sex on treatment and outcome in chronic heart failure.

@nl

P1433

Q37877792-BD9C52B2-C699-49BF-8536-CD1564E33669

P1476

Q37877792-5BD2ABDA-14E3-4F38-9290-409005C106A2

P2093

Q37877792-068A0B8A-770C-449C-8D9D-71ECC1FF7E04

Q37877792-A80C69AC-1D09-432E-AC15-DDB936EFF570

P2860

Q37877792-03E7AED3-C82F-429D-BF32-8C1365694CFE

Q37877792-07A35648-EED5-43DC-A574-0D593745E7F8

Q37877792-08658F7F-DC81-44DD-A880-7B40989E9ACC

Q37877792-08D6B033-EA94-4684-900D-5B0B42D00C61

Q37877792-093AA187-928D-4C35-AD41-1C9548E9FFF1

Q37877792-0A196175-6BCE-4F60-8382-78F00612DC0C

Q37877792-0E69BD73-7209-450F-B8EC-99D53D81EB26

Q37877792-0ECC95CA-2FB9-4BBF-8DF7-B009ABCC4726

Q37877792-12A2294D-775A-4D13-A6CD-6BDE9F1E1797

Q37877792-1B9DB6E0-A340-43C7-A107-ED411CB271A5

P304

Q37877792-6AC8F2B3-D3A2-4160-8856-4FAD692565B7

P31

Q37877792-028E2CA8-E2F8-48A5-B808-50593D1319BB

P356

Q37877792-6D3354D6-2761-47A1-B073-238CCE95F293

P433

Q37877792-4856CBEB-5543-4F11-AC22-DE6CCCFF9379

P478

Q37877792-F9351CB2-F319-4094-B9CA-8CE00E5E0A33

P50

Q37877792-4855C9AD-C9D1-4C31-8B3D-24F2C0D2251B

P577

Q37877792-289CC8E8-2A10-4B2D-B8C1-EECF6754054D

P5875

Q37877792-C64907B7-A7D8-45F7-AC80-22B1C5397DA6

P698

Q37877792-C8EAEE51-3293-4317-8D26-904117ED4C64

P921

Q37877792-3DA7E080-33CB-452D-B424-D36093B72A76

P356

J.1755-5922.2010.00253.X

P1433

Cardiovascular Therapeutics

P1476

Influence of sex on treatment and outcome in chronic heart failure

@en

P2093

Andrew L Clark

http://www.w3.org/2001/XMLSchema#string

Jorge P Ribeiro

http://www.w3.org/2001/XMLSchema#string

P2860

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design

Does heart failure therapy differ according to patient sex?

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).

P304

182-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2010.00253.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51153547

http://www.w3.org/2001/XMLSchema#string

P698

21599874

http://www.w3.org/2001/XMLSchema#string

P921